Agios Pharmaceuticals (AGIO)

$48.55 0.56 (1.17%)

16:00 EDT AGIO Stock Quote Delayed 30 Minutes

7 Best Biotech Stocks to Buy in 2021 with Huge Upside

By Alex Sirois Aug 25, 2021

Biotech stocks are worth considering. Risk aside, big pharma firms can still produce big pharma returns at the end of the day.

5 Biotech Stocks That Could Face M&A Next!

Agios Pharmaceuticals, Inc.Stock Is an Analyst Darling for Good Reason

7 ‘Strong Buy’ Stocks With 100% Wall Street Support

Volume:

Previous Close -

Market Cap 2.86B

PE Ratio 2.14

EPS 22.7

Volume (Avg. Vol.) 330,716

Day's Range 47.26 - 48.75

52-Week Range 32.47 - 62.15

Dividend & Yield N/A (N/A)

AGIO Stock Predictions, Articles, and Agios Pharmaceuticals News

From InvestorPlace
From the Web

Liberty Sirius XM Group (LSXMK) Lead 12 Activist Investor Reports

By Fintel Apr 25, 2017

Recent 13-D and 13-G filings are windows into activist investors activity. We look at Liberty Sirius XM Group and 11 others

40 Biotechnology Stocks to Sell Now

By Portfolio Grader Dec 12, 2016

This week, the overall grades of 40 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

40 Biotechnology Stocks to Sell Now

By Portfolio Grader Dec 5, 2016

The overall ratings of 40 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Why Agios Pharmaceuticals Inc (AGIO), LPL Financial Holdings Inc (LPLA) and Humana Inc (HUM) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer Dec 5, 2016

Agios (AGIO), LPL Financial (LPLA) and Humana (HUM) were wishing the weekend could have lasted one more day on Monday.

10 Stocks That Should Be in Your Portfolio Right Now

By Johnson Research Group Sep 22, 2016

These 10 stocks to buy are the perfect way to load up before the seasonally strong October-through-December period.

22 Biotechnology Stocks to Sell Now

By Portfolio Grader Jul 11, 2016

This week, 22 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

7 Healthcare Stocks That Are Portfolio Poison

By Louis Navellier, Editor, Growth Investor Jan 15, 2016

The market loves to watch a stock grow as much as a parent loves to watch their child grow. Buy, much like toddlers, these healthcare stocks are tumbling.

3 Stocks With Plunging Prices

By James Brumley, InvestorPlace Feature Writer Dec 23, 2014

Here's why Agios Pharmaceuticals Inc (AGIO), Zulily Inc (ZU) and Aruba Networks, Inc. (ARUN) are three of today's worst stocks.

5 Overhyped Stocks to Sell Now

By James Brumley, InvestorPlace Feature Writer Dec 5, 2014

Zoetis, Apple, Yahoo!, and a couple of other overhyped stocks are ripe for pullbacks. Don't wait for the meltdown to start before heading for the exit.

11 Biotechnology Stocks to Buy Now

By Portfolio Grader Nov 12, 2014

This week, 11 biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

9 Biotechnology Stocks to Buy Now

By Portfolio Grader Aug 27, 2014

This week, nine biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

8 Biotechnology Stocks to Buy Now

By Portfolio Grader Aug 6, 2014

The grades of eight biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").